252 related articles for article (PubMed ID: 38342655)
21. F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile Carcinoma.
Ottenhof SR; Djajadiningrat RS; Versleijen MWJ; Donswijk ML; van der Noort V; Brouwer OR; Graafland NM; Vegt E; Horenblas S
Eur Urol Focus; 2022 Jan; 8(1):98-104. PubMed ID: 33685842
[TBL] [Abstract][Full Text] [Related]
22. PET Imaging for Gynecologic Malignancies.
Friedman SN; Itani M; Dehdashti F
Radiol Clin North Am; 2021 Sep; 59(5):813-833. PubMed ID: 34392921
[TBL] [Abstract][Full Text] [Related]
23. Dual-phase F-18 FDG PET-CT in staging and lymphoscintigraphy for detection of sentinel lymph nodes in oral cavity cancers.
Sürücü E; Polack BD; Demir Y; Durmuşoğlu M; Ekmekçi S; Sarıoğlu S; Çelik AO; Ada E; İkiz AÖ
Clin Imaging; 2015; 39(5):781-6. PubMed ID: 25721710
[TBL] [Abstract][Full Text] [Related]
24. Lymph Node Staging with a Combined Protocol of
Weissinger M; Taran FA; Gatidis S; Kommoss S; Nikolaou K; Sahbai S; Fougère C; Brucker SY; Dittmann H
J Nucl Med; 2021 Aug; 62(8):1062-1067. PubMed ID: 33509973
[TBL] [Abstract][Full Text] [Related]
25. Present and future role of FDG-PET/CT imaging in the management of gynecologic malignancies.
Kitajima K; Ebina Y; Sugimura K
Jpn J Radiol; 2014 Jun; 32(6):313-23. PubMed ID: 24744135
[TBL] [Abstract][Full Text] [Related]
26. Molecular Imaging and Precision Medicine in Uterine and Ovarian Cancers.
Zukotynski KA; Kim CK
PET Clin; 2017 Oct; 12(4):393-405. PubMed ID: 28867111
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
28. Nuclear Medicine and Molecular Imaging in Nodal Staging and Surveillance of Ocular Melanoma: Case Reports and Review of the Literature.
Zurcher KS; Houghton OM; Shen JF; Seetharam M; Roarke MC; Yang M
J Nucl Med Technol; 2021 Sep; 49(3):275-280. PubMed ID: 33820860
[TBL] [Abstract][Full Text] [Related]
29. DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile cancer.
Jakobsen JK; Frahm Nielsen T; Ipsen P; Albrecht-Beste E; Cardoso Costa J; Alslev L; Predbjørn Krarup K; Grønkaer Toft B; Høyer S; Bouchelouche K; Bjerggaard Jensen J
BJU Int; 2021 Feb; 127(2):254-262. PubMed ID: 33448605
[TBL] [Abstract][Full Text] [Related]
30. Positron emission tomography scanning in gynecologic and breast cancers.
Zimny M; Siggelkow W
Curr Opin Obstet Gynecol; 2003 Feb; 15(1):69-75. PubMed ID: 12544505
[TBL] [Abstract][Full Text] [Related]
31. Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography.
Williams AD; Cousins C; Soutter WP; Mubashar M; Peters AM; Dina R; Fuchsel F; McIndoe GA; deSouza NM
AJR Am J Roentgenol; 2001 Aug; 177(2):343-8. PubMed ID: 11461859
[TBL] [Abstract][Full Text] [Related]
32. F-18 fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers.
Dolanbay M; Ozcelik B; Abdulrezzak U; Serin IS; Kutuk MS; Uludag S
Arch Gynecol Obstet; 2016 Jun; 293(6):1319-24. PubMed ID: 26498604
[TBL] [Abstract][Full Text] [Related]
33. Emerging Molecular Imaging Techniques in Gynecologic Oncology.
Lin G; Lai CH; Yen TC
PET Clin; 2018 Apr; 13(2):289-299. PubMed ID: 29482755
[TBL] [Abstract][Full Text] [Related]
34. DaPeCa-3: promising results of sentinel node biopsy combined with (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in clinically lymph node-negative patients with penile cancer - a national study from Denmark.
Jakobsen JK; Alslev L; Ipsen P; Costa JC; Krarup KP; Sommer P; Nerstrøm H; Toft BG; Høyer S; Bouchelouche K; Jensen JB
BJU Int; 2016 Jul; 118(1):102-11. PubMed ID: 26216234
[TBL] [Abstract][Full Text] [Related]
35. Current Status of Fibroblast Activation Protein Imaging in Gynecologic Malignancy and Breast Cancer.
Dendl K; Koerber SA; Watabe T; Haberkorn U; Giesel FL
PET Clin; 2023 Jul; 18(3):345-351. PubMed ID: 37257985
[TBL] [Abstract][Full Text] [Related]
36. Preoperative pelvic MRI and 2-[
Fasmer KE; Gulati A; Dybvik JA; Wagner-Larsen KS; Lura N; Salvesen Ø; Forsse D; Trovik J; Pijnenborg JMA; Krakstad C; Haldorsen IS
Eur Radiol; 2023 Jan; 33(1):221-232. PubMed ID: 35763096
[TBL] [Abstract][Full Text] [Related]
37. Gynecologic tumor board: a radiologist's guide to vulvar and vaginal malignancies.
Chow L; Tsui BQ; Bahrami S; Masamed R; Memarzadeh S; Raman SS; Patel MK
Abdom Radiol (NY); 2021 Dec; 46(12):5669-5686. PubMed ID: 34435227
[TBL] [Abstract][Full Text] [Related]
38.
Xiao L; Yu S; Xu W; Sun Y; Xin J
Korean J Radiol; 2023 Nov; 24(11):1142-1150. PubMed ID: 37899523
[TBL] [Abstract][Full Text] [Related]
39. PET/CT in gynecologic malignancies.
Brunetti J
Radiol Clin North Am; 2013 Sep; 51(5):895-911. PubMed ID: 24010912
[TBL] [Abstract][Full Text] [Related]
40. Position of nuclear medicine modalities in the diagnostic work-up of breast cancer.
Buscombe JR; Holloway B; Roche N; Bombardieri E
Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):109-18. PubMed ID: 15243412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
